Evidence map›Paper›PMID 10562309›Full record

ArticleThe Journal of clinical investigation1999

Regulation of smooth muscle cell migration and integrin expression by the Gax transcription factor.

B Witzenbichler, Y Kureishi, Z Luo, A Le Roux, D Branellec, K Walsh

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma.Investigative ophthalmology & visual science · 2019
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. p55γ functional mimetic peptide N24 blocks vascular proliferative disorders.Journal of molecular medicine (Berlin, Germany) · 2015
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

B WitzenbichlerDivision of Cardiovascular Research, St. Elizabeth's Medical Center of Boston, Tufts University School of Medicine, Boston, Massachusetts 02135, USA.
Y Kureishi
Z Luo
A Le Roux
D Branellec
K Walsh
St. Elizabeth's Medical Center · USTufts University · US

Funding

MOLECULAR CONTROL OF MYOGENESISR01AR040197 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI WALSH, KENNETH · 1991 to 2005
$1.4M
REGULATION OF VESSEL WALL APOPTOSISR01AG015052 · NIA · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI WALSH, KENNETH · 1998 to 2002
$1.0M
TRANSCRIPTIONAL CONTROL OF CARDIOVASCULAR PATHOLOGYR01HL050692 · NHLBI · CARITAS ST. ELIZABETH'S MEDICAL CENTER · PI WALSH, KENNETH · 1993 to 2001
$660k
NHLBI NIH HHS R01HL50692NIAMS NIH HHS R01 AR040197NIAMS NIH HHS R01AR40197NIA NIH HHS R01 AG015052NIA NIH HHS R01AG15052
6 · The paper itself

Abstract

Homeobox transcription factors specify body plan by regulating differentiation, proliferation, and migration at a cellular level. The homeobox transcription factor Gax is expressed in quiescent vascular smooth muscle cells (VSMCs), and its expression is downregulated by vascular injury or other conditions that lead to VSMC proliferation. Previous investigations demonstrate that Gax may regulate VSMC proliferation by upregulating the cyclin-dependent kinase (cdk) inhibitor p21. Here we examined whether Gax influences VSMC migration, a key feature in the development of stenotic lesions after balloon injury. Transduction of a Gax cDNA inhibited the migratory response of VSMCs toward PDGF-BB, basic fibroblast growth factor, or hepatocyte growth factor/scatter factor. Gax expression also inhibited migration of NIH.3T3 fibroblasts and embryonic fibroblasts lacking p53. Gax was unable to inhibit the migration of fibroblasts lacking p21, but this effect could be restored in these cells by providing exogenous p21 or by overexpressing another cdk inhibitor, p16. Flow cytometric analysis implicated a Gax-mediated downregulation of alpha(v)beta(3) and alpha(v)beta(5) integrin expression in VSMCs as a potential cause for reduced cell motility. Gax specifically downregulated beta(3) and beta(5) in VSMCs in culture and after acute vascular injury in vivo. Repression of integrin expression was also found in NIH 3T3 cells and p53 knockout fibroblasts, but not in p21-knockout fibroblasts, unless these cells express exogenous p21 or p16. These data suggest that cycle progression, integrin expression, and cell migration can be regulated in VSMCs by the homeobox gene product Gax.

Indexed as

Gene Expression Regulation3T3 CellsAnimalsAorta, ThoracicBecaplerminCell MovementCells, CulturedCell SurvivalFibroblast Growth Factor 2Genes, HomeoboxHepatocyte Growth FactorHomeodomain ProteinsIntegrinsKineticsMaleMiceBecaplerminFibroblast Growth Factor 2Hepatocyte Growth FactorHomeodomain Proteinsintegrin alphaVbeta5IntegrinsMeox2 protein, ratMuscle ProteinsPlatelet-Derived Growth FactorProto-Oncogene Proteins c-sisReceptors, Platelet-Derived Growth FactorReceptors, VitronectinRecombinant ProteinsTranscription Factors

Identifiers

PMID10562309
PMCPMC409839
OpenAlexW2162104331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.